Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepines.
D000818:Animals; D001569:Benzodiazepines / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D001570:Benzodiazepinones / Q000494:pharmacology*; D002415:Cats; D003975:Diazepam / Q000009:adverse effects; D005260:Female; D005442:Flumazenil; D006801:Humans; D008140:Lorazepam / Q000009:adverse effects; D008297:Male; D051379:Mice; D051381:Rats; D012453:Saimiri; D013375:Substance Withdrawal Syndrome / Q000139:chemically induced*; D019966:Substance-Related Disorders / Q000503:physiopathology*; D014229:Triazolam / Q000009:adverse effects
D001570:Benzodiazepinones; D001569:Benzodiazepines; D014229:Triazolam; D005442:Flumazenil; D008140:Lorazepam; D003975:Diazepam